X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (89) 89
index medicus (74) 74
female (70) 70
male (67) 67
cardiac & cardiovascular systems (58) 58
middle aged (57) 57
aged (55) 55
cardiovascular (37) 37
treatment outcome (33) 33
percutaneous coronary intervention (29) 29
myocardial infarction (27) 27
cardiology (23) 23
mortality (23) 23
cardiology and cardiovascular medicine (22) 22
heart attacks (22) 22
myocardial infarction - therapy (22) 22
prognosis (22) 22
patients (20) 20
risk factors (20) 20
adult (19) 19
prospective studies (19) 19
aged, 80 and over (17) 17
care and treatment (16) 16
follow-up studies (16) 16
acute coronary syndromes (15) 15
cardiovascular disease (15) 15
heart attack (15) 15
platelet aggregation inhibitors - therapeutic use (15) 15
angioplasty (14) 14
stents (14) 14
surgery (14) 14
abridged index medicus (13) 13
cardiovascular diseases (13) 13
coronary angiography (13) 13
coronary artery disease (13) 13
electrocardiography (13) 13
internal medicine (13) 13
thrombosis (13) 13
time factors (13) 13
trial (13) 13
analysis (12) 12
drug-eluting stents (12) 12
intervention (12) 12
registry (12) 12
acute coronary syndrome (11) 11
acute myocardial infarction (11) 11
kaplan-meier estimate (11) 11
management (11) 11
medical research (11) 11
myocardial infarction - mortality (11) 11
outcomes (11) 11
research article (11) 11
risk (11) 11
risk assessment (11) 11
clopidogrel (10) 10
concrete (10) 10
coronary-artery-disease (10) 10
guidelines (10) 10
health aspects (10) 10
transluminal angioplasty (10) 10
cancer (9) 9
cardiac patients (9) 9
clinical medicine (9) 9
heart failure (9) 9
medical prognosis (9) 9
medicine, experimental (9) 9
registries (9) 9
stenosis (9) 9
bare-metal stents (8) 8
coronary artery disease - therapy (8) 8
coronary heart disease (8) 8
coronary vessels (8) 8
europe (8) 8
follow-up (8) 8
mathematical models (8) 8
medicine (8) 8
percutaneous coronary intervention - methods (8) 8
revascularization (8) 8
tavi (8) 8
ticlopidine - analogs & derivatives (8) 8
usage (8) 8
acute myocardial-infarction (7) 7
artery-disease (7) 7
aspirin (7) 7
elevation (7) 7
hospitals (7) 7
ischemia (7) 7
medicine, general & internal (7) 7
myocardial infarction - diagnosis (7) 7
optical coherence tomography (7) 7
pancreatic cancer (7) 7
percutaneous coronary intervention - adverse effects (7) 7
peripheral vascular disease (7) 7
predictive value of tests (7) 7
primary percutaneous coronary intervention (7) 7
research (7) 7
science (7) 7
st-segment elevation (7) 7
studies (7) 7
therapy (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 6/2008, Volume 29, Issue 12, pp. 1495 - 1503
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1303 - 1313
This clinical trial compared two antiplatelet regimens during PCI: oral clopidogrel and intravenous cangrelor. As compared with clopidogrel, cangrelor resulted... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | METAANALYSIS | TICAGRELOR | CARDIOVASCULAR EVENTS | ACHIEVE OPTIMAL MANAGEMENT | CLOPIDOGREL PRETREATMENT | PRASUGREL | STANDARD THERAPY | ANTIPLATELET THERAPY | STRATEGIES | Double-Blind Method | Ticlopidine - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Adenosine Monophosphate - analogs & derivatives | Hemorrhage - etiology | Intention to Treat Analysis | Myocardial Ischemia - therapy | Ticlopidine - adverse effects | Female | Aged | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects | Thrombosis - mortality | Platelet Aggregation Inhibitors - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Cangrelor | Angioplasty | Patient outcomes | Product/Service Evaluations | Hemorrhage | Risk factors | Control | Ischemia | Dosage and administration | Drug therapy | Myocardial infarction | Adenosine | Heart attacks | Intravenous administration | Thrombosis | Patients | Bleeding | Dyspnea | Implants | Clopidogrel | Acute coronary syndromes | Respiration
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0164786
Objective Takotsubo syndrome (TS) is a heart condition characterised by a sudden transient left ventricular dysfunction; its pathophysiology is probably... 
MERCURY | ALLERGY | PROGESTERONE | MULTIDISCIPLINARY SCIENCES | CARDIOMYOPATHY | SENSITIVITY | STRESS | ASSOCIATION | PREGNANCY | Humans | Middle Aged | Takotsubo Cardiomyopathy - immunology | Metals - immunology | Male | Hypersensitivity, Delayed - immunology | Mercury - immunology | Lymphocyte Activation - immunology | Pilot Projects | Drug Hypersensitivity - immunology | Aged, 80 and over | Adult | Environment | Female | Aged | Arthritis, Rheumatoid - immunology | Heart | Allergy | Rheumatoid factor | Medical research | Care and treatment | Comorbidity | Metals | Thyroid diseases | Medicine, Experimental | Catecholamines | Degassing of metals | Allergic reaction | Transformation | Hypersensitivity (delayed) | Cardiomyopathy | Arthritis | Dermatitis | Lymphocytes | Lymphocyte transformation | Chronic obstructive pulmonary disease | Cardiology | Thyroid | Chronic illnesses | Antigens | Statistical analysis | Internal medicine | Hypersensitivity | Cell division | Patients | Heavy metals | Asthma | Medicine | Hypotheses | Hospitals | Reactivity | Contact dermatitis | Rheumatoid arthritis | Ventricle | Mercury | Cancer | Mercury (metal) | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Naturvetenskap | Medical and Health Sciences | Medicin och hälsovetenskap | Annan naturvetenskap | Natural Sciences | Klinisk medicin | Other Natural Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 11, pp. 991 - 1001
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e48851
Objectives: The aim of the work was to find biomarkers identifying patients at high risk of adverse clinical outcomes after TAVI and SAVR in addition to... 
REPLACEMENT | MORTALITY | EUROSCORE | PLASMA | SCORE | MULTIDISCIPLINARY SCIENCES | NATRIURETIC PEPTIDE | Biomarkers - metabolism | Malondialdehyde - metabolism | Prognosis | Prospective Studies | Oxidative Stress | Risk Assessment | Humans | Middle Aged | Cardiac Catheterization - adverse effects | Extracellular Matrix - metabolism | Heart Valve Prosthesis Implantation - methods | Male | Treatment Outcome | Aortic Valve Stenosis - therapy | Kidney - metabolism | Algorithms | Heart Valve Prosthesis Implantation - adverse effects | Cardiac Catheterization - methods | Aged, 80 and over | Female | ROC Curve | Aged | Aortic Valve Stenosis - surgery | Nitric Oxide - metabolism | Medical research | Cysteine | Analysis | Aortic valve stenosis | Patient outcomes | Ferritin | Medicine, Experimental | Biological markers | Cystatin | Oxidative stress | Surgical implants | Heart attacks | Peptides | Heart surgery | Stenosis | Risk | Cardiovascular disease | Biochemistry | Matrix metalloproteinase | Multivariate analysis | Tissue inhibitor of metalloproteinase 1 | Consortia | Surgery | Cystatin C | Extracellular matrix | Aorta | Physiology | Mathematical models | Bioindicators | Metalloproteinase | Safety | Glutathione | Heart failure | Risk groups | Mortality | Implantation | Metabolism | Patients | Reclassification | Malondialdehyde | Gelatinase B | Medicine | Hospitals | Deoxyguanosine | Medical prognosis | Predictions | Biomarkers | Homocysteine | Aortic valve
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 13, pp. 1208 - 1217
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article